In the field of interventional therapy of coronary heart disease, cutting balloon is a special kind of balloon. It is a new technology combining micro cutting technology with traditional balloon dilatation. However, high-tech barriers once monopolized the market for foreign products. At the end of 2020, Lepu Medical Technology (Beijing) Co.Ltd(300003) vesscide cutting balloon system was officially listed, completely breaking the monopoly of foreign enterprises and filling the gap of similar products made in China. The advent of domestic cutting balloon system provides technologically advanced and high-quality coronary intervention treatment for patients with coronary heart disease, It has promoted the “interventional non implantation” treatment of coronary heart disease in China to a new level.
It is learned from a tertiary hospital in Shanxi province that not long ago, the hospital successfully completed an operation of cutting balloon and neovas bioabsorbable stent in the treatment of patients with coronary heart disease. The patient recently had chest pain, chest tightness and other symptoms after activities. After going to the hospital for examination, it was found that there was stenosis in coronary vessels, of which the stenosis rate of one section was as high as 80%, and stents need to be implanted for treatment. However, the patient is a young man in his 40s who is worried about lifelong implantation of traditional metal stents. After condition analysis and communication with the patient, the doctor finally selected the treatment scheme of vesscide cutting balloon and neovas bioabsorbable stent for the patient. After the operation, the patient’s chest pain and other symptoms disappeared and received good treatment results.
vesscide cutting balloon: cutting plaque, resisting vascular elastic retraction, and improving the effect of interventional therapy for coronary heart disease
It is understood that the two innovative products used in this operation were developed by Lepu Medical Technology (Beijing) Co.Ltd(300003) China’s leading interventional device company, of which vesscide cutting balloon is the only similar domestic product on the market at present. The surface of the balloon is longitudinally equipped with 3-4 rows of micro blades, which can cut plaques and expand the blood vessel wall, and finally achieve the purpose of benefiting the blood vessel lumen. After the balloon is delivered to the lesion, the micro blade on the balloon will gradually extend out of the balloon surface with the pressure to expand the balloon, and then the effect of treating or fully pretreating the diseased blood vessels can be achieved by cutting plaques and expanding blood vessels. Compared with ordinary balloons, cutting balloons can not only obtain greater benefits from the lumen, but also significantly reduce the elastic retraction of the vascular lumen Risk of irregular dissection and acute occlusion.
This cutting balloon of Lepu is applicable to all coronary atherosclerotic lesions that can be treated by ordinary balloons. It has more obvious advantages in mild to moderate calcification lesions, mouth and bifurcation lesions, in stent restenosis and small vessel lesions. At the same time, the cutting balloon can not only be used as a treatment device alone, but also be used with metal stents, drug balloons Bioabsorbable stent and other devices are used in combination to significantly optimize its therapeutic effect.
patients with “intervention without implantation” have shown long-term benefits, and a variety of innovative products help patients recover
In recent years, with the popularization of the concept of “intervention without implantation” of coronary heart disease and the increasing experience in clinical application, the long-term benefits of patients brought by innovative products have gradually appeared, which has attracted more attention of doctors and patients. At present, Lepu Medical Technology (Beijing) Co.Ltd(300003) has laid out three new products with the concept of “intervention without implantation” in this field: neovas bioabsorbable stent, vesselin coronary drug balloon and vesscide cutting balloon. This series of products can rely on their different advantages to provide more accurate and rich surgical treatment schemes for patients with coronary heart disease and clinicians. It is believed that in the near future, with the development of science and technology and the continuous exploration of enterprises, more Innovation Medical Management Co.Ltd(002173) devices will be available, which will benefit more patients with coronary heart disease and build a stronger barrier to protect the “heart” health.
